Home › Hidradenitis Suppurativa › NCT05507125
Regulation of Inflammatory Genes in Hidradenitis Suppurativa
Who can join
Ages 18 to 89 · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosed with hidradenitis suppurativa * Not Pregnant Exclusion Criteria: * Mild/general dermatological issues like moles, other cosmetic issues * Patients with hidradenitis suppurativa, psoriasis, roasacea, atopic dermatitis and other inflammatory skin disease * Pregnant
About the study
The purpose of this protocol is to examine the cytokine profi le of pati ents with hidradeniti s suppurati va (HS) and idemechanisms responsible for post-transcripti onal regulati on of these genes. The primary objecti ve is to determinfollowing cytokines linked to hidradeniti s suppurati va are diff erenti ally expressed in hidradeniti s pati ents versus controlalso doing a sub-study to determine the eff ect of childhood trauma on HS. The parti cipati on in the sub-study is opti onal
What is being tested
- Mental health (behavioral)
Sponsor: University of Alabama at Birmingham · Participants: 200 · Started: Oct 11, 2022
Contact the study team
- Nabiha Yusuf · Phone: 2059347432
Official record on ClinicalTrials.gov — NCT05507125
Locations in the U.S.
| Alabama | Whitaker Clinic, Birmingham |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.